Skip to content

GBR Versus Allogenic Bone Block

Allogenic Bone Blocks and Particulate Graft for Horizontal Bone Augmentation in the Posterior Mandible: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07295041
Enrollment
37
Registered
2025-12-19
Start date
2018-05-01
Completion date
2025-01-01
Last updated
2025-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar Bone Grafting, Implant Placement

Keywords

bone block, GBR, guided bone regeneration, allogenic graft, bone particulate, allogenic bone block, allogenic bone particulate

Brief summary

This study aimed to compare two different methods used to augment bone in the posterior lower jaw prior to implant placement in patients with insufficient bone width. Eligible patients were included in the study and received a horizontal bone augmentation with one of two methods, which differed in the materials used for the bone augmentation. The group allocation was randomised. After 6 months of healing following parameters were assessed: histological evaluation, survival of the bone graft, the need for further bone augmentation at the time of implant placement, changes in soft tissue characteristics, radiologically and clinically assessed changes in bone width.

Detailed description

Objective: The objective of this study is to compare the histological, clinical, and radiographic outcomes of particulate bone substitutes versus allogenic bone block grafts for primary bone augmentation in the posterior mandible. Materials and Methods: This randomised controlled clinical trial included adult patients in need for a staged bone augmentation prior to implant placement in the posterior mandible. Patients were randomly assigned to one of two treatments groups. Patients allocated in the BBL group received allogenic bone blocks, whereas patients in the GBR group received allogenic bone granules for the primary bone augmentation. In both groups grafting materials were covered with a resorbable collagen membrane, which was fixated with non-resorbable fixation pins. The primary outcome of this study was defined as the composition of the histological samples at least 6 months after the primary bone augmentation. Secondary outcomes included graft survival rates, the need for further augementation procedures at time of implant placement, soft tissue measurements and radiographically and clinically analyzed changes in bone width and radiographically analyzed changes in bone volume. These outcomes were measured at baseline (prior to bone augmentation surgery) and at the follow-up (at least 6 months after bone augmentation).

Interventions

PROCEDUREallogenic bone blocks

An allogenic bone blocks were used for the primary bone augmentation procedure.

PROCEDUREallogenic cancellous bone granules

allogenic cancellous bone granules were used for the primary bone augmentation procedure.

Sponsors

Algirdas Puisys, DDS, PhD
Lead SponsorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged ≥18 years * Insufficient bone width in posterior mandible requiring staged bone augmentation prior to implant placement * Minimum of 1 mm bone width available * Willing to provide signed informed consent

Exclusion criteria

* Pregnant or lactating * Known or suspected incompliance * Patients smoking more than 10 cigarettes per day * Systemic diseases or medications affecting bone metabolism (such as osteoporosis, intake of bisphosphonates) * Active periodontal disease

Design outcomes

Primary

MeasureTime frameDescription
Histological composition6 monthsHistological samples were obtained at the time of reentry for implant placement at least 6 months after the primary bone augmentation procedure. Sample analysis included the measurement of the total sample area, the area of identified bone, biomaterial and soft tissue per sample. Furthermore, the percentage of bone, biomaterial and soft tissue per sample was calculated.

Secondary

MeasureTime frameDescription
Keratinized tissue heightBaseline and 6 monthskeratinized tissue height measured with a periodontal probe at baseline and follow-up.
Vertical soft tissue thicknessBaseline and 6 monthsthe vertical soft tissue thickness measured with a periodontal probe at baseline and follow-up.
Need for further augmentation procedures at the time of implant placement6 monthsThe need for further soft and hard tissue augmentation procedures at the time of implant placement was evaluated at the time of implant placement.
Radiologically measured bone widthBaseline and 6 monthsBucco-oral bone width in the augmented region was measured on baseline and follow-up CBCTs.
Changes in bone volumeBaseline and 6 monthsCBCT images prior to bone augmentation and after the healing period were superimposed. The changes in bone volume in the augmented area were measured.
Clinically measured bone widthBaseline and 6 monthsthe bucco-oral bone width measured with a periodontal probe at baseline and follow-up.

Countries

Lithuania

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026